Osteochondromas and enchondromas are the most common tumors affecting the skeleton. Osteochondromas can occur as multiple lesions, such as those in patients with hereditary multiple exostoses. Unexpectedly, while studying the role of b-catenin in cartilage development, we found that its conditional deletion induces ectopic chondroma-like cartilage formation in mice. Postnatal ablation of b-catenin in cartilage induced lateral outgrowth of the growth plate within 2 weeks after ablation. The chondroma-like masses were present in the flanking periosteum by 5 weeks and persisted for more than 6 months after b-catenin ablation. These long-lasting ectopic masses rarely contained apoptotic cells. In good correlation, transplants of b-catenin-deficient chondrocytes into athymic mice persisted for a longer period of time and resisted replacement by bone compared to control wild-type chondrocytes. In contrast, a b-catenin signaling stimulator increased cell death in control chondrocytes. Immunohistochemical analysis revealed that the amount of detectable b-catenin in cartilage cells of osteochondromas obtained from hereditary multiple exostoses patients was much lower than that in hypertrophic chondrocytes in normal human growth plates. The findings in our study indicate that loss of b-catenin expression in chondrocytes induces periosteal chondroma-like masses and may be linked to, and cause, the persistence of cartilage caps in osteochondromas. (Am J Pathol 2013, 182: 917e927; http://dx
Osteochondromas and enchondromas are the most common tumors affecting the skeleton. Osteochondromas can occur as multiple lesions, such as those in patients with hereditary multiple exostoses. Unexpectedly, while studying the role of b-catenin in cartilage development, we found that its conditional deletion induces ectopic chondroma-like cartilage formation in mice. Postnatal ablation of b-catenin in cartilage induced lateral outgrowth of the growth plate within 2 weeks after ablation. The chondroma-like masses were present in the flanking periosteum by 5 weeks and persisted for more than 6 months after b-catenin ablation. These long-lasting ectopic masses rarely contained apoptotic cells. In good correlation, transplants of b-catenin-deficient chondrocytes into athymic mice persisted for a longer period of time and resisted replacement by bone compared to control wild-type chondrocytes. In contrast, a b-catenin signaling stimulator increased cell death in control chondrocytes. Immunohistochemical analysis revealed that the amount of detectable b-catenin in cartilage cells of osteochondromas obtained from hereditary multiple exostoses patients was much lower than that in hypertrophic chondrocytes in normal human growth plates. The findings in our study indicate that loss of b-catenin expression in chondrocytes induces periosteal chondroma-like masses and may be linked to, and cause, the persistence of cartilage caps in osteochondromas. Osteochondromas and enchondromas are the most common tumors affecting the skeleton. 1, 2 Osteochondromas are cartilage-covered masses that form near the growth plate and bone surface, whereas enchondromas form within the growth plate and bone marrow. Both types of benign tumors can cause mechanical impairment of movement and also pain due to impingement or compression of nerves and blood vessels, particularly when they are present at multiple sites. 3, 4 These benign tumors may become malignant. 5e7 The potential for malignant progression is greater in patients with syndromes, such as Ollier disease, Maffucci syndrome, or hereditary multiple exostoses (HME), the latter also known as multiple osteochondroma.
5e7 Current treatments largely rely on surgical excision. 3, 8 Both benign and malignant cartilage tumors are generally resistant to chemotherapy and radiotherapy. 5, 9 Thus, a better understanding of the cellular and molecular mechanisms underlying cartilage tumor formation and growth is critical for the development of new therapeutic strategies and treatments.
Recent studies have indicated that several genes play important roles in cartilage tumor formation. 4 , 5 Hopyan et al 10 found mutations in parathyroid hormone receptor 1 (PTHR1) in patients with multiple enchondromas. These authors generated mice harboring the same PTHR1 mutations that displayed a similar enchondroma formation. In addition, they found that the PTHR1 mutations caused constitutive activation of hedgehog signaling in cultured chondrocytes and that overexpression of Gli2, a downstream molecule of hedgehog signaling, induced enchondromas in mice. 10 In the follow-up studies, however, it was found that certain cohorts of enchondromatosis patients do not have PTHR1 mutations 11 and that enchondroma formation may actually be independent of hedgehog signaling. 12 Thus, the pathogenesis of enchondroma formation remains to be clarified.
Mutations in EXT1 and EXT2 genes have been associated with hereditary multiple exostoses (HME) (multiple osteochondroma). 5e7 Mutations in these genes are often missense or frame shift and cause synthesis of lower levels of (and shorter) heparan sulfate chains. 4, 5 This is because EXT1 and EXT2 encode Golgi-associated enzymes are responsible for the polymerization of the chains. 13 Insufficiency of heparan sulfate-rich proteoglycans is thought to be a cause of osteochondroma formation. 4, 5, 13 Heparan sulfate proteoglycans are important for the regulation of many signaling pathways that include hedgehog, bone morphogenetic protein, fibroblast growth factor, and Wnt pathways. 13, 14 All of these pathways are critical regulators for chondrogenic differentiation and chondrocyte differentiation. 15, 16 It is likely that dysregulation of these signaling pathways resulting from heparan sulfate deficiency may trigger abnormal behavior of growth plate chondrocytes or induce ectopic chondrogenic differentiation, leading to ectopic cartilage formation. Recently, several Ext mutant mouse lines have been established. 17e19 All of these transgenic mouse lines show multifocal ectopic cartilaginous masses with microscopical and structural similarities to osteochondromas found in HME patients. 17e19 The cellular and molecular mechanisms underlying EXT mutationassociated chondroma formation, however, remains largely unclear.
The Wnt/b-catenin signaling pathway is essential for regulation of normal cartilage development, maintenance of permanent cartilage, and growth plate function. Previous reports have shown that inactivation of this signaling pathway impairs cartilage and skeletal development. Conditional ablation of the b-catenin gene in limb skeletogenic cells induces a delay in endochondral bone formation and the formation of abnormal cartilaginous masses during embryonic development. 25e27 In addition, overexpression of a Wnt antagonist strongly inhibits both hypertrophy of chondrocytes and progression of endochondral ossification. 28 Recently, we generated compound transgenic mice in which we induced postnatal conditional ablation of b-catenin in cartilage. 24 We found that the resulting b-catenin deficiency impaired growth plate function and skeletal growth. In addition, the mice developed ectopic cartilaginous masses located near the bone surface but not within the bone marrow. In the present study, we characterized the pathohistology of these ectopic cartilaginous masses and investigated their possible cell origin and fate, and also related the findings to human osteochondromas.
Materials and Methods

Transgenic Mice
All mouse studies were conducted with approval by the Institutional Animal Care and Use Committee. CagCreER;b-catenin fl/fl mice were generated by mating b-catenin fl/fl mice with CagCreER mice that harbor a tamoxifeninducible Cre (CreER) driven by the chick b-actin promoter/ enhancer coupled to the cytomegarovirus immediate-early enhancer STOCK Tg(CAG-cre/Esr1*)5Amc/J from the Jackson Laboratory. Col2CreER;Ext1 þ/À mice were generated by mating Ext1 þ/À mice 17 and then mated with Ext1 floxed (Ext1 fl/ fl ) mice, 31 and the resulting littermates, Col2CreER; Ext1 fl/À and Ext1 fl/À received i.p. injections of tamoxifen (100 mg/10 mL per mouse) at day 5 and 7 after birth. Col2CreER;Ext1 fl/fl mice were also generated and received 100 mg/10 mL i.p. injections of tamoxifen per mouse at day 5 after birth. The mice were sacrificed 2 weeks after completion of the tamoxifen injections.
Histological, Histochemical, and Immunohistochemical Analyses
Knee joints were dissected, fixed with 4% (v/v) paraformaldehyde, decalcified with EDTA for 7 to 10 days, and fl/fl mice. The ratio of the PCNA-positive cell number to the total cell number was calculated. Localization of collagen 10 was detected by immunohistochemical staining with an anti-collagen 10 antibody. Sections were treated with 0.1% pepsin in 0.02 N HCl for 10 minutes at 37 C, incubated with anti-collagen 10 antibody rabbit serum (1:1000; Cosmo Bio, Tokyo, Japan) in 10% goat serum in PBS for 1 hour at room temperature, followed by visualization of the antibody using the SuperPicture Polymer detection kit (Life Technologies) and counterstaining with methyl green. The sections that had been stained with nonimmune rabbit IgG (5 mg/mL; Vector Laboratories, Burlingame, CA) did not show specific staining.
To evaluate localization of osteoclasts, tartrate-resistant acid phosphatase (TRAP) staining was performed using a TRAP staining kit (Sigma-Aldrich, St. Louis, MO) by following the manufacturer's protocol.
The mouse growth plate paraffin sections were incubated with the rabbit polyclonal antieb-catenin antibody (1:250; Cell Signaling Technology, Inc., Danvers, MA), followed by incubation with horseradish peroxidase conjugated antirabbit antibody (1:100; Vector Laboratories) and ImmPACT SG peroxidase substrate (Vector Laboratories) with methyl green counter staining.
Skeletal Analysis
Limb skeletons were analyzed by taking soft X-ray images using Bioptics piXarray100 (Core Medical Imaging, Inc., Kenmore, WA) using the automatic exposure mode. The knee joints and ribs were stained with alcian blue and alizarin red.
Chondrocyte Cultures
Chondrocytes were isolated from the epiphyseal cartilage from B6129SF2/J mice (Jackson Laboratory) at day 3 to 5 after birth. The epiphyseal cartilage pieces were digested with 0.05% trypsin in HBSS for 1 hour at 37 C and were then incubated with 86 U/mL collagenase type I (Worthington Biochemical Corporation, Lakewood, NJ) in serum-free Dulbecco's modified Eagle's medium overnight. The dissociated cells were plated on collagen 1 coated wells at the density of 30,000 cells per well in 96-well plates or 50,000 cells per well in 4-well culture slides (BD Biosciences, San Jose, CA) and cultured in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum (Gemini Bio-Products, West Sacramento, CA). The cultures were incubated with 6BIO or Me-7BIO (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) in the presence or absence of 3 mmol/L CaCl 2 and 6 mmol/L NaH 2 PO 4 for 24 to 48 hours and subjected to a cell viability assay or terminal deoxynucleotidyl transferase-mediated dUTP 
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The American Journal of Pathology -ajp.amjpathol.orgnick-end labeling (TUNEL) assay. To examine cell viability, the cultures were incubated with 120 mg/mL 3-(4,5-dimethylthiazol-2-yl)À2,5-diphenyltetrazolium bromide (MTT, Life Technologies) in PBS for 1 hour at 37 C and then solubilized with 0.04N HCl in isopropanol. The absorbance was measured at 595 nm. The MTT (Life Technologies) substrate is converted to purple formazan by mitochondrial reductase. The conversion rate is used as a measure of viable cells. The cultures were also fixed with 3.7% neutralized formalin and subjected to a TUNEL assay using the ApopTag red in situ apoptosis detection kit (EMD Millipore Corporation) followed by DAPI nuclear staining.
Epiphyseal chondrocytes were also isolated from CagCreER;b-catenin fl/fl mice and the control b-catenin
littermates at days 3e5 after birth. The cultures were treated with 1 mmol/L 4-hydroxytamoxifen (Sigma-Aldrich) for 48 hours, followed by incubation without 4-hydroxytamoxifen for the additional 48 hours, harvested, and mixed with a collagen solution (3 mg/mL Cellmatrix; Nitta Gelatin Inc., Osaka, Japan) at the concentration of 6.0 to 8.0 Â 10 6 /mL by following the manufacturer's protocol. There was 250 mL per mouse cell mixture that was subcutaneously injected into athymic mice (CD-1 Nude Mouse; Charles River Laboratories International, Inc., Wilmington, MA). Transplants were collected 4 weeks later and subjected to histological inspection. The parallel cultures were harvested and subjected to immunoblot analysis to detect b-catenin and ERK using the antieb-catenin antibody (1 mg/mL; BD Biosciences) and the anti-ERK antibody (1:1000; Cell Signaling Technology, Inc.).
To remove heparan sulfate proteoglycan, the chondrocytes isolated from B6129SF2/J mice were pre-treated with heparinase I from Flavobacterium heparium (SigmaAldrich) at 10 unit/mL for 16 hours and subjected to Topflash reporter analysis 32 using a dual reporter kit (Promega, Madison WI).
Human Tissues
Paraffin sections of osteochondromas surgically removed from consenting HME patients, as well as rib cartilage removed during autopsy, were provided by the Pathology Core of the Children's Hospital of Philadelphia. The slides we used in this study had been made for clinical diagnosis, but were no longer needed and were completely deidentified before being provided for the present study. The study was determined to be nonhuman subjects' research by The Children's Hospital of Philadephia Research Institute's Institutional Review Board.
The sections were treated with 0.1% pepsin in 0.02 N HCl for 10 minutes at 37 C after deparaffinization, blocked with 10% goat serum in PBS for 1 hour, and incubated with the antieb-catenin mouse antibody (1 mg/mL, BD Biosciences) or nonimmune mouse IgG (1 mg/mL, Vector Laboratories) at 4 C overnight. The sections were then incubated with Alexa
Fluor 594-labeled anti-mouse IgG (1 mg/mL) for 1 hour at room temperature followed by DAPI staining for nuclei. The images were taken with a Nikon Eclipse TE2000-U 
Statistical Methods
Results were analyzed using InStat 3 version 3.1a (GraphPad Software, Inc., La Jolla, CA). A one-way analysis of variance with a Tukey-Kramer Multiple Comparison Test was used to identify the differences. The threshold for significance for all tests was set as P < 0.05. Tamoxifen mice showed no obvious abnormality ( Figure 1, A and B) . The knee joints and ribs were harvested and stained with alcian blue and alizarin red to inspect skeletal deformity and possible formation of ectopic cartilage. The costochondral junctions of ribs in the tamoxifen-injected Col2CreER; b-catenin fl/fl mice were swollen ( Figure 1G ) and displayed ectopic cartilaginous masses that were positive for alcian blue staining ( Figure 1G ). In contrast, ribs in the tamoxifeninjected control mice were normal ( Figure 1C ). Ectopic cartilaginous masses were also detected in tibias and femurs of the tamoxifen-injected Col2CreER;b-catenin fl/fl mice ( Figure 1H ), but not in the controls ( Figure 1D ). Similar outcomes were seen using the other Col2CreER (DC) mouse line. The Col2CreER;b-catenin fl/fl mice that had not received a tamoxifen injection did not show any significant skeletal abnormality (data not shown).
Results
Formation of Multiple Ectopic Cartilaginous Masses in
To examine the histology of ectopic cartilaginous masses, we prepared longitudinal sections of knee joints that had been harvested from the tamoxifen-injected Col2CreER; b-catenin fl/fl or the control b-catenin fl/fl mice at 2 (Figure 2 , A, C, E, G, and I) or 5 weeks (Figure 2, B, D, F, H , and J) after completion of the tamoxifen injections. The ectopic masses were present along the lateral side of the tibia and femur growth plates in the direction of the metaphysis in the injected Col2CreER;b-catenin fl/fl mice at 2 weeks after the tamoxifen injections ( Figure 2C ), and were present in both the distal femur and proximal tibia (Figure 2, C, E, and G) . Growth plates of the control b-catenin fl/fl mice were normal (Figure 2A ). Five weeks after the tamoxifen injections, the ectopic cartilaginous masses were embedded in the periosteum (Figure 2 , D, F, H, and J). They retained a columnar structure, but did not contain typical hypertrophic cells ( Figure 2F ). Both mutant femur and tibia showed decreased bone volume ( Figure 2D ) compared to the controls ( Figure 2B ), as previously reported. 24 Some ectopic cartilaginous masses were disconnected from the growth plate ( Figure 2J) . Interestingly, the ectopic masses showed similarities to those in the Ext mutant mice, which have been reported as osteochondroma animal models.
17e19 Indeed, we confirmed that conditional Ext1 ablation caused formation of similar outgrowths near the growth plates at early time points after gene ablation was induced (Supplemental Figure S1 ). In addition, b-catenin immunostaining revealed that the growth plate of Col2CreER;Ext1 fl/fl mice injected with tamoxifen at P5 (100 mg/10 mL per mouse) ;Rosa-LacZ mice (C) received 100 mg/10 mL i.p. injections of tamoxifen per mouse at P5 and P7. Longitudinal sections of knee joints were prepared at 1 (AeC), 2 (D and E), or 8 (F) weeks after completion of the tamoxifen injections and subjected to b-galactosidase staining. B and E: Magnified images of the boxed areas in A and D, respectively.
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Characterization of b-Catenin-Deficient Chondrocytes
Next, we generated Col2CreER;b-catenin fl/fl mice in R26Rosa-lox-stop-lox-LacZ background and examined where the Cre activity was induced and how the Cre-sensitive cells contributed to ectopic cartilage formation by monitoring Cre-induced LacZ activity. One week after completion of the tamoxifen injections, a large number of LacZ positive cells were present in the entire cartilage, but hardly any were present in the perichondrium and periosteum (Figure 3 Figure 3C ). The ectopic cartilaginous masses present at 2 weeks after the tamoxifen injections were composed of both LacZ-positive and negative cells, and the hypertrophic cells in the outgrowing lesions were mostly negative ( Figure 3, D and E) . Eight weeks after the last tamoxifen injection, the ectopic cartilage masses did not contain enlarged hypertrophic cells and were largely composed of LacZ-positive cells ( Figure 3F ). These findings suggest that the b-catenin-deficient cells autonomously form the ectopic cartilage masses and could originate from the growth plate.
PCNA staining was performed to examine cell proliferating activity. The PCNA-positive cells were evenly located Figure 4D ) as compared with the outgrowing lesion ( Figure 4C) . A semiquantitative analysis supported this observation (Figure 4E ), indicating that the chondrocytes in the center of the growth plate in b-catenin deficient mice exhibited lower proliferating activity that those in the outgrowths.
Then we compared the ectopic cartilaginous masses at the initial and later stages. The outgrowing masses at 2 weeks after the tamoxifen injections showed phenotypic characteristics similar to those of the normal growth plates, including collagen 10 expression in the hypertrophic zone ( Figure 5C ), presence of apoptotic cells (Figure 5 , E and G), and TRAP-positive osteoclasts ( Figure 5I ) under the hypertrophic zone. There were no significant changes in expression levels of collagen 10 and the number of apoptotic cells and TRAP-positive cells in control versus b-catenin-deficient growth plates, although the latter were structurally overgrowing. At the later stages, the majority of cells in the ectopic masses were still positive for PCNA ( Figure 5B ). Collagen 10-producing cells ( Figure 5D ) and apoptotic cells were not found ( Figure 5, F and H) , although TRAP-positive cells were detected adjacent to the ectopic cartilage ( Figure 5J ). These findings indicate that the ectopic chondrocytes retained their proliferating activity and did not undergo hypertrophy and apoptosis.
The ectopic cartilaginous masses were still present at 6 months after the tamoxifen injections. The cartilaginous masses gradually increased in volume, bulging into adjacent skeletal muscles (Supplemental Figure S2A) . Microscopy of these lesions showed proliferating chondrocytes, cytological atypia, including bi-nucleated cells (arrows), and prominent vascularity reminiscent of capillary ingrowth (Supplemental Figure S2B) . Disorganization of tissues and the appearance of atypical cells in the cartilaginous masses were observed in each of three separate samples (Supplemental Figure S2 , BeD).
The previously described data indicated that loss of b-catenin rendered chondrocytes more resistant to bone replacement in the process of endochondral ossification. To test this possibility more directly, we isolated chondrocytes from the compound mice (CagCreER;b-catenin fl/fl ) harboring floxed b-catenin and a tamoxifen-inducible Cre (CreER) driven by the chick b-actin promoter/enhancer coupled to the cytomegalovirus immediate-early enhancer (CagCreER). The chondrocytes from CagCreER;b-catenin fl/fl and b-catenin fl/fl mouse cartilage were treated with 1 mmol/L 4-hydroxytamoxifen for 2 days; immunoblot analysis confirmed that the former contained no detectable b-catenin, whereas the control cells did ( Figure 6D ). Both populations were transplanted subcutaneously into athymic mice. The control chondrocyte transplants were completely replaced by bone and fatty marrow by 4 weeks (Figure 6A ), whereas the tissue formed by b-catenin-deficient chondrocytes showed resistance to bone replacement and persisted as a cartilaginous mass ( Figure 6B ) comprising heterogeneous cells ( Figure 6C ).
To further examine the normal roles of b-catenin signaling on cell apoptosis, we treated normal chondrocytes with 6BIO, a stimulator of the Wnt/b-catenin signaling pathway. Treatment with 6BIO changed the cell morphology, and many cells were shrunken and had irregular cell membranes ( Figure 7B ). TUNEL staining revealed that 
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b-Catenin in Human Osteochondromas and Growth Plates
Osteochondromas typically contain a cartilage cap and underlying bone. Surgically retrieved cartilage caps from HME patients and rib growth plate sections from fetal autopsies were subjected to immunohistochemical analysis of b-catenin. We divided the cartilage caps into two regions (Supplemental Figure S3A ): a surface region generally consisting of single cells ( Figure 8I ) and a deeper part located closer to the bone consisting of relatively large cells ( Figure 8J ). We only observed relatively weak b-catenin staining in some of the solitary cells and large cells (Figure 8, A, B , E, and F). The resting zone and hypertrophic zone in the control growth plates were separately inspected (Supplemental Figure S3B) . The degree of b-catenin staining was very low in the resting zone (Figure 8 , C and G), but fairly high in the hypertrophic zone ( Figure 8, D and H) . The number of b-cateninepositive cells in the cartilage caps was comparable to that seen in the resting zone but was much lower than that in the hypertrophic zone ( Figure 8M ), suggesting that cartilage /Pi) for 24 hours and were subjected to a cell viability assay. *P < 0.05. ajp.amjpathol.org -The American Journal of Pathology caps in osteochondromas in HME patients have lower b-catenin signaling activity than that present in normal growth plates.
Discussion
Mechanisms of Ectopic Chondroma-Like Mass Formation in the b-Catenin Deficient Mice
We demonstrate here that postnatal conditional ablation of bcatenin induces formation of periosteal cartilage masses in mice.
Our data relate well with those in previous studies showing that loss of b-catenin can induce ectopic cartilage formation during embryogenesis. 26, 27 These reports have also indicated that bcatenin signaling is required for osteoblast differentiation of mesenchymal cells and that the absence of b-catenin induces mesenchymal cell differentiation into chondrocytes. In our mouse models, Cre-recombinase activity was largely limited to cartilage and was essentially undetectable in noncartilaginous tissues, including perichondrium and periosteum. The data suggest that ectopic cartilage originates via abnormal expansion of the growth plate into the lateral site of perichondrium and is eventually embedded within the periosteum with time. It is therefore likely that ectopic cartilage formation is largely induced by abnormal behavior and function of growth plate chondrocytes in our models. However, we cannot exclude the possibility that neodifferentiation of perichondrium or periosteum-associated skeletal progenitor cells into chondrocytes may also contribute to ectopic cartilage formation.
Our data offers insights into possible mechanisms by which cartilage outgrowths form. One possibility is suggested by the apparent differences in chondrocyte proliferation in the central versus peripheral portions of mutant growth plates. The rates appear to be higher in the lateral part than in the Figure 8 Immunolocalization of b-catenin in ostechondromas and rib growth plates. AeL: Sections of osteochondromas from HME patients (A, B, E, F, I, and J) and rib growth plate obtained from autopsy (C, D, G, H, K, and L) were subjected to immunofluorescence staining for b-catenin. Cartilage caps of osteochondromas were divided into two parts: a region composing of solitary and relatively small cells (Solitary), and a region adjacent to the bone and composed of relatively large cells (Large). Resting zone (Resting) and hypertrophic zone (Hypertrophy) of growth plates were separately inspected. AeD: b-catenin staining; (EeH) merged images of b-catenin staining (red) and DAPI nuclear staining (blue); (IeL) phase contrast images (AeD), respectively. M: Ratios of b-catenin positive cells were evaluated as previously described (see Materials and Methods). *P < 0.05.
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The American Journal of Pathology -ajp.amjpathol.orgcenter growth plate revealed by PCNA staining. This imbalance of cell proliferating activity could derange coordinated longitudinal expansion of the growth plate and lead to lateral overgrowth. In addition, the perichondrium flanking the outgrowing growth plate in the tamoxifen-injected mutant mice appears thinner than that in the control growth plate. Such alteration could decrease the mechanical strength of the perichondrium, resulting in deformation and outgrowth of the growth plate. The outgrowing growth plate initially contained hypertrophic cells positive for collagen 10 and apoptotic cells at the base. These cells had not activated Cre-recombinase, as determined by b-galactosidase activity in Col2CreER;b-catenin fl/fl mice in Rosa-LacZ background. In contrast, the ectopic cartilaginous masses embedded in the periosteum at later stages did not contain collagen 10 positive cells and apoptotic cells, and most of the cells were b-galactosidase-positive and likely b-catenin-deficient. Furthermore, transplants of b-catenindeficient chondrocytes into athymic mice were not replaced by bone and remained cartilaginous for long periods of time. Wnt/b-catenin signaling has been demonstrated to stimulate cell proliferation and survival in various types of cells, especially in cancer cells. 35, 36 However, activation of this signaling stimulates apoptosis, as well as proliferation in intestinal epithelial cells in vivo 37 and also controls frequency of apoptosis in hematopoietic stem/progenitor cells through suppressing Bcl2 expression. 38 Furthermore, overexpression of b-catenin causes cell death independently of its transactivation function. 39 Thus b-catenin could regulate apoptosis in chondrocytes through multiple mechanisms and contexts.
Taken together, our data indicate that hypertrophic cells within the outgrowing lesion did not undergo ablation of the b-catenin gene, but were brought along by the b-catenindeficient chondrocytes during deformation of the growth plate, proceeded toward the endochondral bone formation process, and were replaced by bone while the b-catenin-deficient cells remained as cartilaginous masses within the periosteum. Thus, the process of ectopic chondroma-like mass formation in our mouse model can be divided into two stages. Loss of b-catenin in the growth plate would initially induce a deformity of the growth plate resulting in lateral outgrowth of the growth plate itself. Subsequently, the b-catenin deficient chondrocytes would resist hypertrophy and apoptosis and would give rise to long-lasting ectopic cartilaginous masses persisting within the periosteum.
b-Catenin Signaling in Chondroma Formation
Recent studies have suggested that dysregulation of hedgehog and fibroblast growth factor signaling results in osteochondroma formation under conditions of deficiency of EXT expression and heparan sulfate production in HME patients. 5, 13 In the present study, we observed similarities in the formation of ectopic chondroma-like masses in between our b-catenin-deficient mice and the Ext mutant mice previously reported to represent HME osteochondroma models. 17e19 The topography and histology of ectopic cartilaginous masses forming in our mouse models show features similar to those in Ext mutants 17e19 in that they both form adjacent to the growth plate in ribs, distal tibiae, and proximal femurs, and they exhibit growth-plate like structures, and persist in the periosteum over time. Similar outgrowths of the growth plate were observed in two different types of mutant mice. 18, 19 However, the deficiency of b-catenin resulted in more severe skeletal deformity as compared to those in Ext mutants, indicating that b-catenin-deficient mice may have additional pathological complications. We also demonstrate here that the cartilage caps present in HME patient osteochondromas contained a much lower number of b-catenin-positive cells as compared to hypertrophic chondrocytes of the normal growth plate. These findings suggest that loss or decrease in b-catenin signaling could be a novel pathway involved in the pathogenesis of osteochondroma formation in HME. Genetic and molecular interactions between the Wnt signaling pathway and heparan sulfate proteoglycans have been demonstrated in Drosophila and vertebrates. 40e44 Furthermore, previous studies have indicated that heparan sulfate proteoglycans stabilize Wnt proteins and modulate Wnt signaling activities negatively or positively. 41,43,45e47 Our in vivo and in vitro results are consistent with these reports. Thus, a deficiency in heparan sulfate may decrease Wnt/b-catenin signaling, which in turn could contribute to long-term persistence of cartilage caps in osteochondromas. ajp.amjpathol.org -The American Journal of Pathology
